EUVIMEDEUVIMED entdecken
Crossref

Venetoclax plus azacitidine as a bridge treatment to allogeneic stem cell transplantation in acute myeloid leukaemia patients

Martin Čerňan, Tomáš Szotkowski

Transfuze a hematologie dnes · 10.03.2026 · 32 (1)

DOI: 10.48095/cctahd202604 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transfuze a hematologie dnes, online erschienen am 06.03.2026. Verfasst von Martin Čerňan und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Čerňan, M., & Szotkowski, T. (2026). Venetoclax plus azacitidine as a bridge treatment to allogeneic stem cell transplantation in acute myeloid leukaemia patients. Transfuze a hematologie dnes, 32(1). https://doi.org/10.48095/cctahd202604

Vancouver

Čerňan M, Szotkowski T. Venetoclax plus azacitidine as a bridge treatment to allogeneic stem cell transplantation in acute myeloid leukaemia patients. Transfuze a hematologie dnes. 2026;32(1). doi:10.48095/cctahd202604

BibTeX
@article{eran2026,
  author = {Čerňan, Martin and Szotkowski, Tomáš},
  title = {Venetoclax plus azacitidine as a bridge treatment to allogeneic stem cell transplantation in acute myeloid leukaemia patients},
  journal = {Transfuze a hematologie dnes},
  year = {2026},
  volume = {32},
  number = {1},
  doi = {10.48095/cctahd202604}
}
Kostenlos starten →